✦ LIBER ✦

A new transgene reporter for in vivo magnetic resonance imaging

✍ Scribed by Genove, Guillem; DeMarco, Ulrike; Xu, Hongyan; Goins, William F; Ahrens, Eric T

Book ID: 109932454
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 505 KB
Volume: 11
Category: Article
ISSN: 1078-8956
DOI: 10.1038/nm1208

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vivo magnetic resonance imaging of tr

In vivo magnetic resonance imaging of transgene expression

✍ Weissleder, Ralph; Moore, Anna; Mahmood, Umar; Bhorade, Rajeev; Benveniste, Hele 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 750 KB

Magnetic resonance imaging of HSV-based

Magnetic resonance imaging of HSV-based in vivo transgene expression

✍ Hoegemann, Dagmar; Ichikawa, Tomo; Chiocca, E.A.; Weissleder, Ralph; Basilion, J 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 32 KB

A new decade for Magnetic Resonance Imag

A new decade for Magnetic Resonance Imaging

✍ John C. Gore 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Low field magnetic resonance imaging in

Low field magnetic resonance imaging in rat in vivo

✍ E. Breton; C. Goetz; P. Choquet; A. Constantinesco 📂 Article 📅 2008 🏛 Elsevier 🌐 French ⚖ 621 KB

Visualization of in vivo electroporation

Visualization of in vivo electroporation-mediated transgene expression in experimental tumors by optical and magnetic resonance imaging

✍ Aung, W; Hasegawa, S; Koshikawa-Yano, M; Obata, T; Ikehira, H; Furukawa, T; Aoki 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 599 KB

Nanoparticle pharmacokinetic profiling i

Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging

✍ Anne M. Neubauer; Hoon Sim; Patrick M. Winter; Shelton D. Caruthers; Todd A. Wil 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB

## Abstract Contrast agents targeted to molecular markers of disease are currently being developed with the goal of identifying disease early and evaluating treatment effectiveness using noninvasive imaging modalities such as MRI. Pharmacokinetic profiling of the binding of targeted contrast agents